Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,801 INR | +0.54% | +2.07% | -6.42% |
05-07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
05-07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.42% | 3.52B | |
+37.96% | 705B | |
+32.82% | 583B | |
-3.72% | 364B | |
+19.78% | 332B | |
+4.94% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.84% | 169B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Downgrades Gland Pharma to Reduce From Neutral, Adjusts Price Target to INR1,157 From INR1,524